Mike Davis, MD, PhD, is the Chief Medical Officer at Usona Institute. In his role, Dr. Davis provides clinical leadership and direction across the organization, including clinical development, medical affairs, pharmacovigilance, and regulatory affairs. Prior to joining Usona, Dr. Davis served as a Lead Physician (Clinical Team Leader) in the Division of Psychiatry at the US Food and Drug Administration (FDA), where he led a team of psychiatrists in the clinical review of Investigational New Drug (IND) and New Drug Applications (NDAs) for psychiatric indications and provided advice to commercial and academic sponsors. During his time at the FDA, Dr. Davis received numerous honors and awards, including the Division of Psychiatry Annual Awards for Individual Supervisor, the Division of Psychiatry Annual Award for Collaboration, and the FDA Outstanding Service Award for exemplary performance and leadership in advancing science in psychiatric drug development.
Dr. Davis completed a Medical Scientist Training Program (MD/PhD) at Case Western Reserve University, psychiatric residency training at the Semel Institute for Neuroscience at Behavior at UCLA, and a clinical research fellowship at the West Los Angeles VA Mental Illness Research, Education, and Clinical Center (MIRECC); his research interests focused on the development of novel therapeutics for serious mental illness. Dr. Davis is licensed to practice medicine and is board certified in Psychiatry. Professionally, Dr. Davis is an active member of the American College of Neuropsychopharmacology (ACNP), the International Society for CNS Clinical Trials and Methodology (ISCTM), and the American Society of Clinical Psychopharmacology (ASCP), and he has presented nationally and internationally on topics including regulatory issues in psychedelic drug development, estimands, and digital health technologies.
In his personal time, Mike enjoys spending time with his family, gardening, tropical fishkeeping, and playing the trumpet.